EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF CHICAGO AND F3 PLATFORM BIOLOGICS, INC.Exclusive License Agreement • June 20th, 2023 • F3 Platform Biologics INC • Pharmaceutical preparations • Illinois
This License Agreement (“Agreement”), dated October 21, 2020 (“Effective Date”), is between The University of Chicago, an Illinois not-for-profit corporation (“University”), and F3 Platform Biologics, Inc., a Delaware corporation (“Company”). Each hereunder may be referred to separately as the “Party”, or together as the “Parties”.
ASSET PURCHASE AGREEMENT by and between F3 PLATFORM BIOLOGICS, INC. and ASSET RECOVERY ASSOCIATES, LLC, AS ASSIGNEE OF ALGAEON, INC. August 20, 2018Asset Purchase Agreement • June 20th, 2023 • F3 Platform Biologics INC • Pharmaceutical preparations • Georgia
F3 Platform Biologics, Inc. Scientific Advisory Board AgreementAdvisory Board Agreement • June 20th, 2023 • F3 Platform Biologics INC • Pharmaceutical preparations • Delaware
This Scientific Advisory Board Agreement (this “Agreement”), effective as of [Date] (the “Effective Date”), is made between F3 Platform Biologics, Inc., a Delaware corporation (the “Company”), and [Name] (“Advisor”).
